Michael T. Cullen

2020

In 2020, Michael T. Cullen earned a total compensation of $611.2K as Executive Chairman at Panbela Therapeutics, a 7% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$141,750
Option Awards$153,400
Salary$316,000
Total$611,150

Cullen received $316K in salary, accounting for 52% of the total pay in 2020.

Cullen also received $141.8K in non-equity incentive plan and $153.4K in option awards.

Rankings

In 2020, Michael T. Cullen's compensation ranked 10,448th out of 13,090 executives tracked by ExecPay. In other words, Cullen earned more than 20.2% of executives.

ClassificationRankingPercentile
All
10,448
out of 13,090
20th
Division
Manufacturing
4,476
out of 5,621
20th
Major group
Chemicals And Allied Products
1,859
out of 2,254
18th
Industry group
Drugs
1,628
out of 1,954
17th
Industry
Pharmaceutical Preparations
1,202
out of 1,459
18th
Source: SEC filing on April 15, 2021.

Cullen's colleagues

We found two more compensation records of executives who worked with Michael T. Cullen at Panbela Therapeutics in 2020.

2020

Jennifer Simpson

Panbela Therapeutics

Chief Executive Officer

2020

Susan Horvath

Panbela Therapeutics

Chief Financial Officer

News

You may also like